CHF 978.56
(0.57%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 525 Million CHF | -11.02% |
2022 | 590 Million CHF | 5.36% |
2021 | 560 Million CHF | 48.35% |
2020 | 377.49 Million CHF | -3.45% |
2019 | 390.98 Million CHF | 6.83% |
2018 | 365.98 Million CHF | 2.81% |
2017 | 355.98 Million CHF | -12.55% |
2016 | 407.09 Million CHF | 6.52% |
2015 | 382.16 Million CHF | 1625.57% |
2014 | 22.14 Million CHF | 28.5% |
2013 | 17.23 Million CHF | 81.38% |
2012 | 9.5 Million CHF | 0.0% |
2011 | - CHF | -100.0% |
2010 | 3.15 Million CHF | 0.0% |
2009 | - CHF | -100.0% |
2008 | 86.12 Million CHF | 13.59% |
2007 | 75.82 Million CHF | -33.51% |
2006 | 114.03 Million CHF | 0.0% |
2005 | - CHF | 0.0% |
2004 | - CHF | 0.0% |
2003 | - CHF | 0.0% |
2002 | - CHF | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 430 Million CHF | 0.0% |
2023 Q2 | 550 Million CHF | 0.0% |
2023 Q4 | 525 Million CHF | 0.0% |
2023 FY | 525 Million CHF | -11.02% |
2022 Q4 | 590 Million CHF | 0.0% |
2022 FY | 590 Million CHF | 5.36% |
2022 Q2 | 530 Million CHF | 0.0% |
2021 Q2 | 497.53 Million CHF | 0.0% |
2021 Q4 | 560 Million CHF | 0.0% |
2021 FY | 560 Million CHF | 48.35% |
2020 Q4 | 377.49 Million CHF | 0.0% |
2020 FY | 377.49 Million CHF | -3.45% |
2020 Q2 | 389.98 Million CHF | 0.0% |
2019 Q4 | 390.98 Million CHF | 0.0% |
2019 FY | 390.98 Million CHF | 6.83% |
2019 Q2 | 340.98 Million CHF | 0.0% |
2018 Q4 | 110 Million CHF | 0.0% |
2018 FY | 365.98 Million CHF | 2.81% |
2018 Q2 | 6 Million CHF | 0.0% |
2017 Q2 | 100 Million CHF | 0.0% |
2017 Q4 | 100 Million CHF | 0.0% |
2017 FY | 355.98 Million CHF | -12.55% |
2016 Q2 | 20 Million CHF | 0.0% |
2016 Q4 | 91.33 Million CHF | 0.0% |
2016 FY | 407.09 Million CHF | 6.52% |
2015 Q2 | 30.12 Million CHF | 0.0% |
2015 Q4 | 10 Million CHF | 0.0% |
2015 FY | 382.16 Million CHF | 1625.57% |
2014 Q4 | 22.14 Million CHF | 0.0% |
2014 FY | 22.14 Million CHF | 28.5% |
2014 Q2 | 19.96 Million CHF | 0.0% |
2013 Q2 | 9.81 Million CHF | 0.0% |
2013 Q4 | 17.23 Million CHF | 0.0% |
2013 FY | 17.23 Million CHF | 81.38% |
2012 Q2 | - CHF | 0.0% |
2012 FY | 9.5 Million CHF | 0.0% |
2012 Q4 | 9.5 Million CHF | 0.0% |
2011 Q2 | - CHF | 0.0% |
2011 Q4 | - CHF | 0.0% |
2011 FY | - CHF | -100.0% |
2010 Q2 | 3.57 Million CHF | 0.0% |
2010 Q4 | 3.15 Million CHF | 0.0% |
2010 FY | 3.15 Million CHF | 0.0% |
2009 Q4 | - CHF | 0.0% |
2009 FY | - CHF | -100.0% |
2008 FY | 86.12 Million CHF | 13.59% |
2007 FY | 75.82 Million CHF | -33.51% |
2006 FY | 114.03 Million CHF | 0.0% |
2005 FY | - CHF | 0.0% |
2004 FY | - CHF | 0.0% |
2003 FY | - CHF | 0.0% |
2002 FY | - CHF | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Relief Therapeutics Holding AG | 4.31 Million CHF | -12078.149% |
Tecan Group AG | 316.09 Million CHF | -66.09% |
Santhera Pharmaceuticals Holding AG | 25.06 Million CHF | -1994.805% |
Basilea Pharmaceutica AG | 128.6 Million CHF | -308.224% |
Bachem Holding AG | 401 Thousand CHF | -130822.693% |
Molecular Partners AG | 3.65 Million CHF | -14275.685% |